Inventor · disambiguated record
Michael C. Milone
Also filed as: MILONE MICHAEL · MILONE MICHAEL C
45 granted patents·39 pending applications·3,333 citations·filing 2011–2025
99Inventor score
Top patents by PatentIndex Score
84 records- 0199US9540445B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Jan 10, 2017·99 cites·30 claims
- 0299US9518123B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Dec 13, 2016·92 cites·26 claims
- 0399US9481728B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2015·Granted Nov 1, 2016·100 cites·30 claims
- 0499US9464140B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Oct 11, 2016·117 cites·28 claims
- 0599US9328156B2Use of chimeric antigen receptor-modified T cells to treat cancerUNIV PENNSYLVANIA·Filed 2013·Granted May 3, 2016·127 cites·15 claims
- 0699US9102761B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·250 cites·30 claims
- 0799US9102760B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·254 cites·30 claims
- 0899US9101584B2Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·250 cites·30 claims
- 0999US8975071B1Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Mar 10, 2015·255 cites·17 claims
- 1099US8916381B1Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Dec 23, 2014·276 cites·28 claims
- 1199US8911993B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Dec 16, 2014·474 cites·21 claims
- 1299US8906682B2Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Dec 9, 2014·507 cites·30 claims
- 1398US9499629B2Use of chimeric antigen receptor-modified T-cells to treat cancerJUNE CARL H·Filed 2011·Granted Nov 22, 2016·151 cites·53 claims
- 1497US10174095B2Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptorNOVARTIS AG·Filed 2015·Granted Jan 8, 2019·41 cites·50 claims
- 1597US9815901B2Treatment of cancer using a CD123 chimeric antigen receptorBROGDON JENNIFER·Filed 2015·Granted Nov 14, 2017·94 cites·40 claims
- 1696US9745368B2Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapyNOVARTIS AG·Filed 2014·Granted Aug 29, 2017·117 cites·23 claims
- 1795US11084880B2Anti-BCMA chimeric antigen receptorNOVARTIS AG·Filed 2018·Granted Aug 10, 2021·15 cites·24 claims
- 1894US10829735B2Methods for improving the efficacy and expansion of immune cellsUNIV PENNSYLVANIA·Filed 2016·Granted Nov 10, 2020·14 cites·28 claims
- 1994US10287354B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2014·Granted May 14, 2019·29 cites·63 claims
- 2094US10273300B2Methods of making chimeric antigen receptor-expressing cellsUNIV PENNSYLVANIA·Filed 2015·Granted Apr 30, 2019·26 cites·28 claims
- 2193US10301370B2Compositions and methods of chimeric autoantibody receptor T cellsUNIV PENNSYLVANIA·Filed 2015·Granted May 28, 2019·6 cites·16 claims
- 2292US10577417B2Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapyNOVARTIS AG·Filed 2015·Granted Mar 3, 2020·10 cites·33 claims
- 2391US12240884B2Methods for improving the efficacy and expansion of immune cellsNOVARTIS AG·Filed 2020·Granted Mar 4, 2025·2 cites·24 claims
- 2491US10774388B2Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereofNOVARTIS AG·Filed 2015·Granted Sep 15, 2020·7 cites·31 claims
- 2590US11890301B2Methods and compositions for cells expressing a chimeric intracellular signaling moleculeUNIV PENNSYLVANIA·Filed 2016·Granted Feb 6, 2024·4 cites·8 claims
- 2688US10851149B2Treatment of cancer using GFR α-4 chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2015·Granted Dec 1, 2020·3 cites·32 claims
- 2785US11407803B2Compositions and methods of chimeric autoantibody receptor T cellsUNIV PENNSYLVANIA·Filed 2019·Granted Aug 9, 2022·1 cites·21 claims
- 2885US10568947B2Treatment of cancer using a CLL-1 chimeric antigen receptorNOVARTIS AG·Filed 2015·Granted Feb 25, 2020·6 cites·38 claims
- 2984US10640553B2Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapyNOVARTIS AG·Filed 2017·Granted May 5, 2020·2 cites·23 claims
- 3083US11578130B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2018·Granted Feb 14, 2023·1 cites·30 claims
- 3183US10703819B2Treatment of cancer using a CD123 chimeric antigen receptorNOVARTIS AG·Filed 2017·Granted Jul 7, 2020·1 cites·33 claims
- 3283US2024343783A1Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapyNOVARTIS AG·Filed 2024·Application pending·0 cites
- 3382US10738099B2Method of redirecting T cells to treat HIV infectionUNIV PENNSYLVANIA·Filed 2016·Granted Aug 11, 2020·2 cites·27 claims
- 3481US2023303653A1Compositions and methods of chimeric autoantibody receptor t cellsUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 3580US2024262884A1Treatment of cancer using gfr alpha-4 chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 3679US2023220090A1Treatment of cancer using a cd123 chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 3779US2025084147A1Method of Redirecting T Cells to Treat HIV InfectionUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 3878US2024317850A1Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapyNOVARTIS AG·Filed 2024·Application pending·0 cites
- 3975US11578113B2Compositions and methods of chimeric autoantibody receptor T cellsUNIV PENNSYLVANIA·Filed 2019·Granted Feb 14, 2023·0 cites·21 claims
- 4075US11407802B2Compositions and methods of chimeric autoantibody receptor T cellsUNIV PENNSYLVANIA·Filed 2019·Granted Aug 9, 2022·0 cites·14 claims
- 4175US11407804B2Compositions and methods of chimeric autoantibody receptor T cellsUNIV PENNSYLVANIA·Filed 2019·Granted Aug 9, 2022·0 cites·19 claims
- 4275US2024342213A1Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling MoleculeUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 4375US2023295296A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 4472US2024398913A1Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 4572US2023026049A1Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 4672US2024026293A1Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling MoleculeUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 4770US12214037B2Treatment of cancer using humanized anti-BCMA chimeric antigen receptorUNIV PENNSYLVANIA·Filed 2021·Granted Feb 4, 2025·0 cites·16 claims
- 4870US11919946B2Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapyNOVARTIS AG·Filed 2020·Granted Mar 5, 2024·0 cites·15 claims
- 4970US11591404B2Treatment of cancer using a CD123 chimeric antigen receptorNOVARTIS AG·Filed 2020·Granted Feb 28, 2023·0 cites·33 claims
- 5070US2020283729A1Treatment of cancer using chimeric antigen receptorNOVARTIS AG·Filed 2019·Application pending·0 cites
Showing the top 50 of 84 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael C. Milone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →